{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:49:13Z","timestamp":1788922153244,"version":"build-2803163510"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T00:00:00Z","timestamp":1760400000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01-DA056331"],"award-info":[{"award-number":["R01-DA056331"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01-DA056675"],"award-info":[{"award-number":["R01-DA056675"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Minnesota, Faculty Research Development (FRD) program"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-025-08790-6","type":"journal-article","created":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T14:54:57Z","timestamp":1760453697000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploiting the angiotensin-converting enzyme pathway to augment endogenous opioid signaling"],"prefix":"10.1038","volume":"8","author":[{"given":"Prakashkumar","family":"Dobariya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6223-8274","authenticated-orcid":false,"given":"Filip","family":"Hanak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0514-2510","authenticated-orcid":false,"given":"Patrick E.","family":"Rothwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8733-2029","authenticated-orcid":false,"given":"Swati S.","family":"More","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,14]]},"reference":[{"key":"8790_CR1","doi-asserted-by":"publisher","unstructured":"Nemoto, W., Yamagata, R., Nakagawasai, O. & Tan-No, K. Angiotensin-related peptides and their role in pain regulation. Biology 12, https:\/\/doi.org\/10.3390\/biology12050755 (2023).","DOI":"10.3390\/biology12050755"},{"key":"8790_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.drudis.2024.104089","volume":"29","author":"KD Bhilare","year":"2024","unstructured":"Bhilare, K. D., Dobariya, P., Hanak, F., Rothwell, P. E. & More, S. S. Current understanding of the link between angiotensin-converting enzyme and pain perception. Drug Discov. Today 29, 104089 (2024).","journal-title":"Drug Discov. Today"},{"key":"8790_CR3","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1126\/science.abl5130","volume":"375","author":"BH Trieu","year":"2022","unstructured":"Trieu, B. H. et al. Angiotensin-converting enzyme gates brain circuit-specific plasticity via an endogenous opioid. Science 375, 1177\u20131182 (2022).","journal-title":"Science"},{"key":"8790_CR4","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/258577a0","volume":"258","author":"J Hughes","year":"1975","unstructured":"Hughes, J. et al. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature 258, 577\u2013580 (1975).","journal-title":"Nature"},{"key":"8790_CR5","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/bs.vh.2019.05.001","volume":"111","author":"E Duque-D\u00edaz","year":"2019","unstructured":"Duque-D\u00edaz, E., Alvarez-Ojeda, O. & Cove\u00f1as, R. Enkephalins and ACTH in the mammalian nervous system. Vitam. Horm. 111, 147\u2013193 (2019).","journal-title":"Vitam. Horm."},{"key":"8790_CR6","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","volume":"89","author":"J Le Merrer","year":"2009","unstructured":"Le Merrer, J., Becker, J. A., Befort, K. & Kieffer, B. L. Reward processing by the opioid system in the brain. Physiol. Rev. 89, 1379\u20131412 (2009).","journal-title":"Physiol. Rev."},{"key":"8790_CR7","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.neuroscience.2005.06.025","volume":"135","author":"MM Nieto","year":"2005","unstructured":"Nieto, M. M., Guen, S. L., Kieffer, B. L., Roques, B. P. & Noble, F. Physiological control of emotion-related behaviors by endogenous enkephalins involves essentially the delta opioid receptors. Neuroscience 135, 305\u2013313 (2005).","journal-title":"Neuroscience"},{"key":"8790_CR8","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000338163","volume":"5","author":"R Nogueiras","year":"2012","unstructured":"Nogueiras, R. et al. The opioid system and food intake: homeostatic and hedonic mechanisms. Obes. Facts 5, 196\u2013207 (2012).","journal-title":"Obes. Facts"},{"key":"8790_CR9","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/1546125","volume":"2017","author":"MS Henry","year":"2017","unstructured":"Henry, M. S., Gendron, L., Tremblay, M. E. & Drolet, G. Enkephalins: endogenous analgesics with an emerging role in stress resilience. Neural Plast. 2017, 1546125 (2017).","journal-title":"Neural Plast."},{"key":"8790_CR10","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1113\/jphysiol.1992.sp019149","volume":"450","author":"Y Hori","year":"1992","unstructured":"Hori, Y., Endo, K. & Takahashi, T. Presynaptic inhibitory action of enkephalin on excitatory transmission in superficial dorsal horn of rat spinal cord. J. Physiol. 450, 673\u2013685 (1992).","journal-title":"J. Physiol."},{"key":"8790_CR11","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/j.neuron.2015.11.010","volume":"88","author":"MR Banghart","year":"2015","unstructured":"Banghart, M. R., Neufeld, S. Q., Wong, N. C. & Sabatini, B. L. Enkephalin disinhibits Mu opioid receptor-rich striatal patches via delta opioid receptors. Neuron 88, 1227\u20131239 (2015).","journal-title":"Neuron"},{"key":"8790_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fnsys.2022.1044686","volume":"16","author":"ST Lubejko","year":"2022","unstructured":"Lubejko, S. T. et al. The role of endogenous opioid neuropeptides in neurostimulation-driven analgesia. Front. Syst. Neurosci. 16, 1044686 (2022).","journal-title":"Front. Syst. Neurosci."},{"key":"8790_CR13","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1124\/jpet.110.172866","volume":"336","author":"JJ Lowery","year":"2011","unstructured":"Lowery, J. J. et al. In vivo characterization of MMP-2200, a mixed \u03b4\/\u03bc opioid agonist, in mice. J. Pharm. Exp. Ther. 336, 767\u2013778 (2011).","journal-title":"J. Pharm. Exp. Ther."},{"key":"8790_CR14","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1002\/jps.10406","volume":"92","author":"JD Huber","year":"2003","unstructured":"Huber, J. D. et al. Conjugation of low molecular weight poly(ethylene glycol) to biphalin enhances antinociceptive profile. J. Pharm. Sci. 92, 1377\u20131385 (2003).","journal-title":"J. Pharm. Sci."},{"key":"8790_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/0014-2999(79)90350-9","volume":"58","author":"RK T\u00fcrker","year":"1979","unstructured":"T\u00fcrker, R. K., Ilhan, M. & Ercan, Z. S. Potentiation by angiotensin converting enzyme inhibitor, SQ, 14225, of the analgesic effect of morphine in mice. Eur. J. Pharm. 58, 99\u2013100 (1979).","journal-title":"Eur. J. Pharm."},{"key":"8790_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/0014-2999(80)90440-9","volume":"63","author":"ZS Ercan","year":"1980","unstructured":"Ercan, Z. S., Ilhan, M. & T\u00fcrker, R. K. Alterations by captopril of pain reactions due to thermal stimulation of the mouse foot: interactions with morphine, naloxone and aprotinin. Eur. J. Pharm. 63, 167\u2013177 (1980).","journal-title":"Eur. J. Pharm."},{"key":"8790_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135504","volume":"741","author":"AS Taskiran","year":"2021","unstructured":"Taskiran, A. S. & Avci, O. Effect of captopril, an angiotensin-converting enzyme inhibitor, on morphine analgesia and tolerance in rats, and elucidating the inflammation and endoplasmic reticulum stress pathway in this effect. Neurosci. Lett. 741, 135504 (2021).","journal-title":"Neurosci. Lett."},{"key":"8790_CR18","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/S0026-895X(25)14191-6","volume":"28","author":"JA Norman","year":"1985","unstructured":"Norman, J. A., Autry, W. L. & Barbaz, B. S. Angiotensin-converting enzyme inhibitors potentiate the analgesic activity of [Met]-enkephalin-Arg6-Phe7 by inhibiting its degradation in mouse brain. Mol. Pharm. 28, 521\u2013526 (1985).","journal-title":"Mol. Pharm."},{"key":"8790_CR19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.coph.2010.11.001","volume":"11","author":"KE Bernstein","year":"2011","unstructured":"Bernstein, K. E. et al. Different in vivo functions of the two catalytic domains of angiotensin-converting enzyme (ACE). Curr. Opin. Pharm. 11, 105\u2013111 (2011).","journal-title":"Curr. Opin. Pharm."},{"key":"8790_CR20","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0006-291X(03)01363-9","volume":"308","author":"JH Fernandez","year":"2003","unstructured":"Fernandez, J. H., Hayashi, M. A., Camargo, A. C. & Neshich, G. Structural basis of the lisinopril-binding specificity in N- and C-domains of human somatic ACE. Biochem. Biophys. Res. Commun. 308, 219\u2013226 (2003).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"8790_CR21","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1042\/BCJ20200060","volume":"477","author":"GE Cozier","year":"2020","unstructured":"Cozier, G. E., Lubbe, L., Sturrock, E. D. & Acharya, K. R. ACE-domain selectivity extends beyond direct interacting residues at the active site. Biochem. J. 477, 1241\u20131259 (2020).","journal-title":"Biochem. J."},{"key":"8790_CR22","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1161\/01.RES.0000081593.33848.FC","volume":"93","author":"D Georgiadis","year":"2003","unstructured":"Georgiadis, D. et al. Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors. Circ. Res. 93, 148\u2013154 (2003).","journal-title":"Circ. Res."},{"key":"8790_CR23","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1161\/HYPERTENSIONAHA.121.17041","volume":"78","author":"R Alves-Lopes","year":"2021","unstructured":"Alves-Lopes, R. et al. Selective inhibition of the C-domain of ACE (angiotensin-converting enzyme) combined with inhibition of NEP (neprilysin): a potential new therapy for hypertension. Hypertension 78, 604\u2013616 (2021).","journal-title":"Hypertension"},{"key":"8790_CR24","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1016\/S0006-2952(97)00087-7","volume":"53","author":"PA Deddish","year":"1997","unstructured":"Deddish, P. A., Jackman, H. L., Skidgel, R. A. & Erd\u00f6s, E. G. Differences in the hydrolysis of enkephalin congeners by the two domains of angiotensin converting enzyme. Biochem. Pharm. 53, 1459\u20131463 (1997).","journal-title":"Biochem. Pharm."},{"key":"8790_CR25","doi-asserted-by":"publisher","unstructured":"Hanak, F. et al. Inhibition of the angiotensin-converting enzyme N-terminal catalytic domain prevents endogenous opioid degradation in brain tissue. bioRxiv https:\/\/doi.org\/10.1101\/2025.01.21.634163 (2025).","DOI":"10.1101\/2025.01.21.634163"},{"key":"8790_CR26","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/0006-2952(71)90292-9","volume":"20","author":"DW Cushman","year":"1971","unstructured":"Cushman, D. W. & Cheung, H. S. Spectrophotometric assay and properties of the angiotensin-converting enzyme of rabbit lung. Biochem. Pharm. 20, 1637\u20131648 (1971).","journal-title":"Biochem. Pharm."},{"key":"8790_CR27","doi-asserted-by":"publisher","first-page":"9388","DOI":"10.1021\/ac901775h","volume":"81","author":"VK Jimsheena","year":"2009","unstructured":"Jimsheena, V. K. & Gowda, L. R. Colorimetric, high-throughput assay for screening Angiotensin I-converting enzyme inhibitors. Anal. Chem. 81, 9388\u20139394 (2009).","journal-title":"Anal. Chem."},{"key":"8790_CR28","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1038\/nprot.2006.349","volume":"1","author":"MA Sentandreu","year":"2006","unstructured":"Sentandreu, M. A. & Toldr\u00e1, F. A fluorescence-based protocol for quantifying angiotensin-converting enzyme activity. Nat. Protoc. 1, 2423\u20132427 (2006).","journal-title":"Nat. Protoc."},{"key":"8790_CR29","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1378\/chest.78.1.69","volume":"78","author":"PK Rohatgi","year":"1980","unstructured":"Rohatgi, P. K. & Ryan, J. W. Simple radioassay for measuring serum activity of angiotensin-converting enzyme in sarcoidosis. Chest 78, 69\u201376 (1980).","journal-title":"Chest"},{"key":"8790_CR30","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1016\/j.foodchem.2009.05.080","volume":"118","author":"V Lahogue","year":"2010","unstructured":"Lahogue, V., R\u00e9hel, K., Taupin, L., Haras, D. & Allaume, P. A HPLC-UV method for the determination of angiotensin I-converting enzyme (ACE) inhibitory activity. Food Chem. 118, 870\u2013875 (2010).","journal-title":"Food Chem."},{"key":"8790_CR31","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/S0021-9673(02)01995-7","volume":"986","author":"S Van Dyck","year":"2003","unstructured":"Van Dyck, S., Vissers, S., Van Schepdael, A. & Hoogmartens, J. Kinetic study of angiotensin converting enzyme activity by capillary electrophoresis after in-line reaction at the capillary inlet. J. Chromatogr. A 986, 303\u2013311 (2003).","journal-title":"J. Chromatogr. A"},{"key":"8790_CR32","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1016\/j.foodchem.2010.12.019","volume":"126","author":"K Inoue","year":"2011","unstructured":"Inoue, K., Kitade, M., Hino, T. & Oka, H. Screening assay of angiotensin-converting enzyme inhibitory activity from complex natural colourants and foods using high-throughput LC-MS\/MS. Food Chem. 126, 1909\u20131915 (2011).","journal-title":"Food Chem."},{"key":"8790_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.jchromb.2006.08.052","volume":"846","author":"CJ van Platerink","year":"2007","unstructured":"van Platerink, C. J., Janssen, H. G. & Haverkamp, J. Development of an at-line method for the identification of angiotensin-I inhibiting peptides in protein hydrolysates. J. Chromatogr. B Anal. Technol. Biomed. Life Sci. 846, 147\u2013154 (2007).","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"8790_CR34","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1017\/S0022029905001639","volume":"73","author":"SM Shalaby","year":"2006","unstructured":"Shalaby, S. M., Zakora, M. & Otte, J. Performance of two commonly used angiotensin-converting enzyme inhibition assays using FA-PGG and HHL as substrates. J. Dairy Res. 73, 178\u2013186 (2006).","journal-title":"J. Dairy Res."},{"key":"8790_CR35","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.ab.2007.02.017","volume":"364","author":"H Lam le","year":"2007","unstructured":"Lam le, H. et al. Assay of angiotensin I-converting enzyme-inhibiting activity based on the detection of 3-hydroxybutyric acid. Anal. Biochem. 364, 104\u2013111 (2007).","journal-title":"Anal. Biochem."},{"key":"8790_CR36","doi-asserted-by":"publisher","first-page":"13","DOI":"10.5812\/thrita.4264","volume":"1","author":"A Kouchmeshky","year":"2012","unstructured":"Kouchmeshky, A., Jameie, S. B., Amin, G. & Ziai, S. A. Investigation of angiotensin-convertings enzyme inhibitory effects of medicinal plants used in traditional Persian medicine for treatment of hypertension: screening study. Thrita J. Neu 1, 13\u201323 (2012).","journal-title":"Thrita J. Neu"},{"key":"8790_CR37","doi-asserted-by":"publisher","first-page":"10685","DOI":"10.1021\/jf403004e","volume":"61","author":"Y Ben Henda","year":"2013","unstructured":"Ben Henda, Y. et al. Measuring angiotensin-I converting enzyme inhibitory activity by micro plate assays: comparison using marine cryptides and tentative threshold determinations with captopril and losartan. J. Agric. Food Chem. 61, 10685\u201310690 (2013).","journal-title":"J. Agric. Food Chem."},{"key":"8790_CR38","doi-asserted-by":"publisher","unstructured":"Yan, Y., Zhang, Y., Liu, M., Li, L. & Zheng, Y. Neuroprotection vs. neurotoxicity: the dual impact of brain lipids in depression. Int. J. Mol. Sci. 26, https:\/\/doi.org\/10.3390\/ijms26062722 (2025).","DOI":"10.3390\/ijms26062722"},{"key":"8790_CR39","doi-asserted-by":"publisher","first-page":"9826","DOI":"10.1021\/jm4009345","volume":"56","author":"L Hocharoen","year":"2013","unstructured":"Hocharoen, L., Joyner, J. C. & Cowan, J. A. N- versus C-domain selectivity of catalytic inactivation of human angiotensin converting enzyme by lisinopril-coupled transition metal chelates. J. Med. Chem. 56, 9826\u20139836 (2013).","journal-title":"J. Med. Chem."},{"key":"8790_CR40","doi-asserted-by":"publisher","first-page":"3656","DOI":"10.1074\/jbc.270.8.3656","volume":"270","author":"A Rousseau","year":"1995","unstructured":"Rousseau, A., Michaud, A., Chauvet, M. T., Lenfant, M. & Corvol, P. The hemoregulatory peptide N-acetyl-Ser-Asp-Lys-Pro is a natural and specific substrate of the N-terminal active site of human angiotensin-converting enzyme. J. Biol. Chem. 270, 3656\u20133661 (1995).","journal-title":"J. Biol. Chem."},{"key":"8790_CR41","doi-asserted-by":"publisher","first-page":"15729","DOI":"10.1021\/bi048423r","volume":"43","author":"PA Bersanetti","year":"2004","unstructured":"Bersanetti, P. A. et al. Positional-scanning combinatorial libraries of fluorescence resonance energy transfer peptides for defining substrate specificity of the angiotensin I-converting enzyme and development of selective C-domain substrates. Biochemistry 43, 15729\u201315736 (2004).","journal-title":"Biochemistry"},{"key":"8790_CR42","doi-asserted-by":"publisher","first-page":"574","DOI":"10.2174\/1573406415666190514081132","volume":"15","author":"M Polakovi\u010dov\u00e1","year":"2019","unstructured":"Polakovi\u010dov\u00e1, M. & Jamp\u00edlek, J. Advances in structural biology of ACE and development of domain selective ACE-inhibitors. Med. Chem. 15, 574\u2013587 (2019).","journal-title":"Med. Chem."},{"key":"8790_CR43","doi-asserted-by":"publisher","first-page":"13398","DOI":"10.1016\/S0021-9258(18)42224-7","volume":"267","author":"L Wei","year":"1992","unstructured":"Wei, L., Clauser, E., Alhenc-Gelas, F. & Corvol, P. The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors. J. Biol. Chem. 267, 13398\u201313405 (1992).","journal-title":"J. Biol. Chem."},{"key":"8790_CR44","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1021\/ml4004588","volume":"5","author":"GJ Kramer","year":"2014","unstructured":"Kramer, G. J. et al. Interkingdom pharmacology of Angiotensin-I converting enzyme inhibitor phosphonates produced by actinomycetes. ACS Med. Chem. Lett. 5, 346\u2013351 (2014).","journal-title":"ACS Med. Chem. Lett."},{"key":"8790_CR45","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1038\/nrd1227","volume":"2","author":"KR Acharya","year":"2003","unstructured":"Acharya, K. R., Sturrock, E. D., Riordan, J. F. & Ehlers, M. R. Ace revisited: a new target for structure-based drug design. Nat. Rev. Drug Discov. 2, 891\u2013902 (2003).","journal-title":"Nat. Rev. Drug Discov."},{"key":"8790_CR46","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.968104","volume":"13","author":"W Zheng","year":"2022","unstructured":"Zheng, W. et al. Small molecule angiotensin converting enzyme inhibitors: a medicinal chemistry perspective. Front. Pharm. 13, 968104 (2022).","journal-title":"Front. Pharm."},{"key":"8790_CR47","doi-asserted-by":"publisher","first-page":"9002","DOI":"10.1016\/S0021-9258(18)31543-6","volume":"266","author":"L Wei","year":"1991","unstructured":"Wei, L., Alhenc-Gelas, F., Corvol, P. & Clauser, E. The two homologous domains of human angiotensin I-converting enzyme are both catalytically active. J. Biol. Chem. 266, 9002\u20139008 (1991).","journal-title":"J. Biol. Chem."},{"key":"8790_CR48","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/bcp.14931","volume":"88","author":"LM Moss","year":"2022","unstructured":"Moss, L. M. et al. First-in-human trial to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of STR-324, a dual enkephalinase inhibitor for pain management. Br. J. Clin. Pharm. 88, 103\u2013114 (2022).","journal-title":"Br. J. Clin. Pharm."},{"key":"8790_CR49","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/bph.15656","volume":"180","author":"B Alvarez-Perez","year":"2023","unstructured":"Alvarez-Perez, B., Poras, H. & Maldonado, R. The inhibition of enkephalin catabolism by dual enkephalinase inhibitor: a novel possible therapeutic approach for opioid use disorders. Br. J. Pharm. 180, 879\u2013893 (2023).","journal-title":"Br. J. Pharm."},{"key":"8790_CR50","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/0014-2999(84)90607-1","volume":"98","author":"P Mojaverian","year":"1984","unstructured":"Mojaverian, P., Swanson, B. N. & Ferguson, R. K. Enalapril, a new nonsulfhydryl angiotensin converting enzyme inhibitor, does not potentiate morphine analgesia. Eur. J. Pharm. 98, 303\u2013306 (1984).","journal-title":"Eur. J. Pharm."},{"key":"8790_CR51","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.npep.2014.05.002","volume":"48","author":"A Bali","year":"2014","unstructured":"Bali, A., Randhawa, P. K. & Jaggi, A. S. Interplay between RAS and opioids: opening the Pandora of complexities. Neuropeptides 48, 249\u2013256 (2014).","journal-title":"Neuropeptides"},{"key":"8790_CR52","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1021\/ja208791f","volume":"134","author":"JC Joyner","year":"2012","unstructured":"Joyner, J. C., Hocharoen, L. & Cowan, J. A. Targeted catalytic inactivation of angiotensin converting enzyme by lisinopril-coupled transition-metal chelates. J. Am. Chem. Soc. 134, 3396\u20133410 (2012).","journal-title":"J. Am. Chem. Soc."},{"key":"8790_CR53","doi-asserted-by":"publisher","first-page":"257","DOI":"10.3389\/fmed.2018.00257","volume":"5","author":"DJ Campbell","year":"2018","unstructured":"Campbell, D. J. Neprilysin inhibitors and bradykinin. Front. Med. 5, 257 (2018).","journal-title":"Front. Med."},{"key":"8790_CR54","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1007\/s00213-024-06706-6","volume":"242","author":"F Mostafa","year":"2025","unstructured":"Mostafa, F., Mantawy, E. M., Said, R. S., Azab, S. S. & El-Demerdash, E. Captopril attenuates oxidative stress and neuroinflammation implicated in cisplatin-induced cognitive deficits in rats. Psychopharmacology, 242, 563\u2013578 (2025).","journal-title":"Psychopharmacology"},{"key":"8790_CR55","doi-asserted-by":"publisher","unstructured":"Nohara, T. et al. Neuroprotective potential of raloxifene via G-protein-coupled estrogen receptors in A\u03b2-oligomer-induced neuronal injury. Biomedicines 11, https:\/\/doi.org\/10.3390\/biomedicines11082135 (2023).","DOI":"10.3390\/biomedicines11082135"},{"key":"8790_CR56","doi-asserted-by":"publisher","first-page":"1694","DOI":"10.1016\/j.freeradbiomed.2006.09.002","volume":"41","author":"MA Ansari","year":"2006","unstructured":"Ansari, M. A. et al. In vivo administration of D609 leads to protection of subsequently isolated gerbil brain mitochondria subjected to in vitro oxidative stress induced by amyloid beta-peptide and other oxidative stressors: relevance to Alzheimer\u2019s disease and other oxidative stress-related neurodegenerative disorders. Free Radic. Biol. Med. 41, 1694\u20131703 (2006).","journal-title":"Free Radic. Biol. Med."},{"key":"8790_CR57","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1038\/288286a0","volume":"288","author":"BP Roques","year":"1980","unstructured":"Roques, B. P. et al. The enkephalinase inhibitor thiorphan shows antinociceptive activity in mice. Nature 288, 286\u2013288 (1980).","journal-title":"Nature"},{"key":"8790_CR58","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1124\/mol.119.119370","volume":"98","author":"GC Gregoriou","year":"2020","unstructured":"Gregoriou, G. C., Patel, S. D., Winters, B. L. & Bagley, E. E. Neprilysin controls the synaptic activity of neuropeptides in the intercalated cells of the amygdala. Mol. Pharm. 98, 454\u2013461 (2020).","journal-title":"Mol. Pharm."},{"key":"8790_CR59","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00586-005-0899-1","volume":"14","author":"G Papadokostakis","year":"2005","unstructured":"Papadokostakis, G., Katonis, P., Damilakis, J. & Hadjipavlou, A. Does raloxifene treatment influence back pain and disability among postmenopausal women with osteoporosis?. Eur. Spine J. 14, 977\u2013981 (2005).","journal-title":"Eur. Spine J."},{"key":"8790_CR60","doi-asserted-by":"publisher","first-page":"2035","DOI":"10.1038\/sj.npp.1300510","volume":"29","author":"LJ Smith","year":"2004","unstructured":"Smith, L. J., Henderson, J. A., Abell, C. W. & Bethea, C. L. Effects of ovarian steroids and raloxifene on proteins that synthesize, transport, and degrade serotonin in the raphe region of macaques. Neuropsychopharmacology 29, 2035\u20132045 (2004).","journal-title":"Neuropsychopharmacology"},{"key":"8790_CR61","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1007\/s11064-011-0659-z","volume":"37","author":"RM Adibhatla","year":"2012","unstructured":"Adibhatla, R. M., Hatcher, J. F. & Gusain, A. Tricyclodecan-9-yl-xanthogenate (D609) mechanism of actions: a mini-review of literature. Neurochem. Res. 37, 671\u2013679 (2012).","journal-title":"Neurochem. Res."},{"key":"8790_CR62","doi-asserted-by":"publisher","first-page":"6097","DOI":"10.1210\/jc.2004-0795","volume":"89","author":"W Gianni","year":"2004","unstructured":"Gianni, W. et al. Raloxifene modulates interleukin-6 and tumor necrosis factor-alpha synthesis in vivo: results from a pilot clinical study. J. Clin. Endocrinol. Metab. 89, 6097\u20136099 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"8790_CR63","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S1016-8478(23)13962-8","volume":"26","author":"SA Lee","year":"2008","unstructured":"Lee, S. A., Park, S. H. & Kim, B. C. Raloxifene, a selective estrogen receptor modulator, inhibits lipopolysaccharide-induced nitric oxide production by inhibiting the phosphatidylinositol 3-kinase\/Akt\/nuclear factor-kappa B pathway in RAW264.7 macrophage cells. Mol. Cells 26, 48\u201352 (2008).","journal-title":"Mol. Cells"},{"key":"8790_CR64","doi-asserted-by":"publisher","first-page":"4007","DOI":"10.1021\/acschemneuro.9b00230","volume":"10","author":"R Singh","year":"2019","unstructured":"Singh, R., Xie, W., Williams, J., Vince, R. & More, S. S. Discovery of anticancer clinical candidate, tosedostat, as an analgesic agent. ACS Chem. Neurosci. 10, 4007\u20134017 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"8790_CR65","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1248\/bpb1978.8.701","volume":"8","author":"M Hachisu","year":"1985","unstructured":"Hachisu, M., Takahashi, H., Hiranuma, T., Shibazaki, Y. & Murata, S. Relationship between enkephalinase inhibition of thiorphan in vivo and its analgesic activity. J. Pharmacobiodyn. 8, 701\u2013710 (1985).","journal-title":"J. Pharmacobiodyn."},{"key":"8790_CR66","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1038\/nrd3673","volume":"11","author":"BP Roques","year":"2012","unstructured":"Roques, B. P., Fourni\u00e9-Zaluski, M.-C. & Wurm, M. Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain. Nat. Rev. Drug Discov. 11, 292\u2013310 (2012).","journal-title":"Nat. Rev. Drug Discov."},{"key":"8790_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2024.116604","volume":"275","author":"R Singh","year":"2024","unstructured":"Singh, R. et al. Modulation of endogenous opioid signaling by inhibitors of puromycin-sensitive aminopeptidase. Eur. J. Med. Chem. 275, 116604 (2024).","journal-title":"Eur. J. Med. Chem."},{"key":"8790_CR68","doi-asserted-by":"publisher","first-page":"45214","DOI":"10.1021\/acsomega.4c06449","volume":"9","author":"A Stefanucci","year":"2024","unstructured":"Stefanucci, A. et al. Elucidation on the in vivo activity of the bivalent opioid peptide MACE2 against several types of chronic pain. ACS Omega 9, 45214\u201345220 (2024).","journal-title":"ACS Omega"},{"key":"8790_CR69","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1021\/acschemneuro.3c00005","volume":"14","author":"A Stefanucci","year":"2023","unstructured":"Stefanucci, A. et al. Design of analgesic trivalent peptides with low withdrawal symptoms: probing the antinociceptive profile of novel linear and cyclic peptides as opioid pan ligands. ACS Chem. Neurosci. 14, 506\u2013515 (2023).","journal-title":"ACS Chem. Neurosci."},{"key":"8790_CR70","doi-asserted-by":"publisher","first-page":"7118","DOI":"10.1021\/bi00243a012","volume":"30","author":"MR Ehlers","year":"1991","unstructured":"Ehlers, M. R. & Riordan, J. F. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes. Biochemistry 30, 7118\u20137126 (1991).","journal-title":"Biochemistry"},{"key":"8790_CR71","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1007\/s13361-016-1521-y","volume":"28","author":"R Dator","year":"2017","unstructured":"Dator, R. et al. A high resolution\/accurate mass (HRAM) data-dependent MS(3) neutral loss screening, classification, and relative quantitation methodology for carbonyl compounds in saliva. J. Am. Soc. Mass Spectrom. 28, 608\u2013618 (2017).","journal-title":"J. Am. Soc. Mass Spectrom."}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08790-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08790-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T03:48:53Z","timestamp":1760500133000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-025-08790-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,14]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8790"],"URL":"https:\/\/doi.org\/10.1038\/s42003-025-08790-6","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,14]]},"assertion":[{"value":"4 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1465"}}